RO-7122290

N/A

Report date: 2025/07/15 20:00:07

Base Information

Drug NameRO-7122290
Drug Alias NameFAP-4-1BBLFAP-4-1BBL FPRO-7122290RG-7827
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsFibroblast activation protein alpha binders
TargetsTumor necrosis factor receptor superfamily member 9Prolyl endopeptidase FAP
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsDenmarkUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A